Supplier Type
- Manufacturer
- Reagent
Supplier Region
- Gujarat(3)
- Mumbai(3)
- Hyderabad(7)
- Ahmedabad(1)
- Bangalore(1)
- Maharashtra(1)
- Pune(2)
- Punjab(1)
- Karnataka(1)
- Nagpur(1)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- NLT 95%
- NLT 90%
- more than 95%
- more than 90%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Greater than 99%
- Empagliflozin intermediate, Dapagliflozin Impurity
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- 99.99%
- 99.98%
- 99.95%
- 99.91%
- 99.86%
- 99.85%
- 99.80%
- 99.73%
- 99.42%
- 99.29%
- 99%
- 98.60%
- 98.12%
- 98%
- 97-99%
- 97.57%
- 97%
- 97 %
- 96.80%
- 96.39%
- 96.14%
- 96%
- 95.48%
- 95.00%
- >95%
- 95%
- 94.00%
- >92%
- 90%
- >90%
- 90 % Above
- 25 MG 50 MG 100 MG 250 MG EXTRA
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 25mg
- 50mg
- 100mg
- 250mg
- 500mg
- 1gm
- 1g
- 5g
- 25g
- 1kg
- 5kg
- 10kg
- 25kg
- 1MT
- 95NLT %
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 1and gm
- 250250 mg.
-
1,6-Naphthyridine-3-carboxylic acid, 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-, (4S)-
2640506-74-5
-
(3aS,5R,6R,6aR)-6-Hydroxy-5-(hydroxymethyl)tetrahydrofuro[2,3-d]oxazol-2(5H)-one
2508-81-8
-
Iloperidone iMpurity
1375651-23-2
-
1-[2-[4-Hydroxy-3-(2-hydroxyethyl)phenyl]ethyl]-α,α-diphenyl-
215032-24-9
-
Posaconazole Impurity 16
213381-02-3
-
Thyroxine-4-hydroxy-3,5-diiodophenyl Ether DISCONTINUED
911661-90-0
-
N-(3-acetyl-4-(2-hydroxy-3-(isopropylaMino)propoxy)phenyl)propionaMide
28197-36-6
-
Atenolol impurity
-
EzetiMibe iMpurity
-
Sofosbuvir IMpurity
1520010-86-9
FINERENONE IMPURITY 13/ACID IMPURITY 2640506-74-5
Atorvastatin impurity 1371615-55-2
Anastrozole Diamide Impurity or Anastrozole Diamide Impurity 120512-04-1
Irinotecan Impurity C 947687-02-7